We report a case with exaggerated stent protrusion from the right coronary ostium into the aorta leading to recurrent inferoposterior and right ventricular myocardial infarctions due to stent thrombosis, which were treated successfully with fibrinolysis. The stent was removed via transverse aortotomy and two bypass grafts were performed. Stents protruding from the aorta may not only cause technical difficulties but also carry a high risk of thrombosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1540-8191.2009.00909.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Recurrent Intra-Stent Coronary Restenosis in a Carrier of Non-Disease-Specific Antinuclear Antibodies.
Eur J Case Rep Intern Med
April 2024
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Article Synopsis
- Intracoronary in-stent restenosis (ISR) often happens 3 to 6 months after stent placement; while drug-eluting stents have reduced ISR, cases still occur.
- An 81-year-old woman with a history of multiple heart procedures experienced reiterant ISR, leading researchers to focus on intra-stent factors after excluding others.
- A diagnosis of potential coronary vasculitis was proposed, possibly triggered by the stent, and the patient's ISR did not recur after starting steroid treatment, highlighting the importance of considering biological causes for effective management.
The Effectiveness of Antiplatelet Therapy and the Factors Influencing It in Patients with Acute Coronary Syndrome before and during the COVID-19 Pandemic.
Medicina (Kaunas)
December 2022
Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
Dual antiplatelet therapy (DAPT) is essential in the treatment of patients with acute coronary syndrome (ACS). The objective of this study was to evaluate the effectiveness of antiplatelet medication in our practice and to investigate the factors that influence it. A prospective cohort observational study was conducted, in which 193 patients with ACS were enrolled.
View Article and Find Full Text PDFIntravascular treatment of long segments of experimental peripheral arteries with multiple, serial, balloon-expandable, resorbable scaffolds.
JVS Vasc Sci
March 2022
Department of Surgery, University of Illinois, Advocate Lutheran General Hospital, Park Ridge, IL.
Symptomatic femoropopliteal occlusive disease has been increasingly treated using endovascular methods. However, restenosis, especially after implantation of permanent metallic stents, has remained common. To date, resorbable scaffolds have failed to achieve sufficient radial strength to enable the successful treatment of long, mobile, peripheral arteries.
View Article and Find Full Text PDFSymptomatic atherosclerotic plaque progression in a first-generation carotid stent: management and 5-year clinical and imaging outcome-a case report.
Eur Heart J Case Rep
January 2022
Department of Cardiac and Vascular Diseases, Jagiellonian University Institute of Cardiology, John Paul II Hospital, ul. Pradnicka 80, 31-202 Krakow, Poland.
Background: Restenosis in first-generation (single-layer) carotid stents (FGS) is believed to represent an exaggerated healing response of (neo)intimal hyperplasia (NIH) formation. Rather than NIH, we describe symptomatic in-FGS unstable plaque (neo)atherosclerosis mandating re-revascularization. To halt continued plaque evolution, we propose a novel treatment strategy involving a microNet-covered stent (MCS, second-generation carotid stent) to sequestrate the plaque from the vessel lumen.
View Article and Find Full Text PDFUnstable Angina Induced by Fracture of a Recently Implanted Drug-Eluting Stent.
J Invasive Cardiol
January 2022
First Department of Cardiology, 'Hippokration' General Hospital, National and Kapodistrian University of Athens, School of Medicine, Vasilissis Sofias Av. 114, 115 27, Athens, Greece.
Stent fracture is a rather infrequent complication associated with in-stent restenosis, thrombosis, aneurysm formation, and ischemic events. Several stent-related parameters, such as the use of longer or multiple stents, stent overlapping, and balloon/stent overexpansion are potential predictors of stent fracture. Stents deployed in right coronary artery lesions with exaggerated motion, tortuosity, or severe calcification are also generally considered to be at higher risk for fracture.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!